Onco Therapies gets UK approval BS Reporter / Chennai September 20, 2011, 0:51 ISTOnco Therapies Ltd, a wholly owned oncology subsidiary of Strides, announced the UK’s approval for Oxaliplatin Injection 5 mgô ml (10 ml, 20 ml and 40 ml). The approval from the rest of the European countries is expected shortly, it said.
